Skip to main content
Equibles
NEOG logo

NEOG · Neogen Corp · Metrics

Track NEOG — free

Use NEOG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NEOG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.79 +0.07 (+0.60%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.56B
Shares
218.31M
Volume · Oct 21 51.86K Avg daily vol (3M) 3.27M

NEOG metrics

100 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$11.72
Market cap
$2.56B

Price action

20 metrics
Price change (1W)
-0.1%
Price change (30D)
-13.9%
Price change (3M)
+18.0%
Price change (6M)
+24.4%
Price change (YTD)
+67.7%
Price change (1Y)
+99.0%
Trailing year
Price change (5Y)
-71.5%
52-week high
$13.98
52-week low
$5.41
Change from 52-week high
-16.2%
Change from 52-week low
+116.6%
Annualized volatility
58.1%
Annualized volatility (3M)
60.7%
Beta
1.5
RSI (14D)
44.0
Price vs SMA 50
-3.7%
Price vs SMA 200
+14.0%
Avg volume (3M)
3.27M
Relative volume
0.7
Average dollar volume
$39.68M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
218.31M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
3.6×
reciprocal yield 28.1%
EV / EBITDA
28.9×
reciprocal yield 3.5%
EV / EBIT
—
P / sales
2.9×
reciprocal yield 34.8%
P / book
1.2
reciprocal yield 82.2%
FCF yield
2.0%
TTM · current market cap
Buyback yield
—
P / FCF
51.0
reciprocal yield 2.0%
P / operating cash flow
29.8
reciprocal yield 3.4%
Earnings yield
-2.2%

Historical valuation

8 metrics
P / E historical average (3Y)
122.2×
reciprocal yield 0.8%
P / E historical average (5Y)
117.2×
reciprocal yield 0.9%
EV / revenue historical average (3Y)
3.7×
reciprocal yield 26.9%
EV / revenue historical average (5Y)
4.8×
reciprocal yield 20.9%
EV / EBIT historical average (3Y)
80.8×
reciprocal yield 1.2%
EV / EBIT historical average (5Y)
70.0×
reciprocal yield 1.4%
EV / EBITDA historical average (3Y)
32.1×
reciprocal yield 3.1%
EV / EBITDA historical average (5Y)
36.0×
reciprocal yield 2.8%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-06

Profitability

9 metrics
Gross margin
47.4%
Operating margin
-0.8%
Trailing 12 months
Net margin
-6.3%
Gross profit (TTM)
$419.00M
Operating profit (TTM)
−$7.30M
Net income (TTM)
−$56.12M
Trailing 12 months
Diluted EPS (TTM)
$-0.26
FCF margin
5.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$4.06
Gross profit per diluted share (TTM)
$1.92
Operating profit per diluted share (TTM)
$-0.03
EBITDA per diluted share (TTM)
$0.50
Net income per diluted share (TTM)
$-0.26
Operating cash flow per diluted share (TTM)
$0.39
Free cash flow per diluted share (TTM)
$0.23
Capital expenditures per diluted share (TTM)
$0.16
R&D per diluted share (TTM)
$0.09
Stock compensation per diluted share (TTM)
$0.05
Book value per share
$9.56

Growth

11 metrics
Revenue growth YoY
+6.5%
Year over year
Net income growth YoY
-132.8%
Revenue (TTM)
$884.00M
Trailing 12 months
EPS growth YoY
-129.4%
Shares change YoY
+0.4%
Year over year · more shares
Revenue CAGR (3Y)
+1.9%
Revenue CAGR (5Y)
+13.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-10.1%

Quality

14 metrics
Return on equity
-2.7%
Return on assets
-1.7%
Debt / equity
0.4
Current ratio
3.9
EBITDA (TTM)
$109.00M
Free cash flow (TTM)
$49.80M
Quick ratio
2.9
Interest coverage
—
Net debt / EBITDA
5.6
Return on invested capital
—
Trailing 12 months
Net cash
−$608.20M
Latest balance sheet
Cash & equivalents
$172.00M
Total assets
$3.30B
Total debt
$793.70M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$85.30M
Capital expenditures (TTM)
$35.50M
R&D (TTM)
$19.80M
SG&A (TTM)
—
Stock compensation (TTM)
$11.50M
R&D / revenue
2.2%
Stock compensation / revenue
1.3%

Ownership (13F)

9 metrics
13F filers
319
13F filer change QoQ
+8
Institutional ownership
109.1%
Conviction holders (share of 13F filers)
0.6%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+2.8%
Holder tenure
11.8
Price vs estimated holder cost
+7.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
28.8%

Short interest

3 metrics
Short interest
5.4%
Latest settlement · 2.0 days to cover
Days to cover
2.0d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
$10,404
Insider-sentiment score
72 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 711377 CUSIP 640491106 13F (30d) 35 filings 35 filers Visit website Investor relations